Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

553.66
Delayed Data
As of Jul 31
 +6.56 / +1.20%
Today’s Change
310.69
Today|||52-Week Range
569.91
+34.96%
Year-to-Date
Will Regeneron (REGN) Earnings Surprise on Eylea Sales? - Analyst Blog
Jul 31 / Zacks.com
Cramer -- Be Careful Buying GrubHub, Biogen Is a Battleground
Jul 27 / TheStreet.com
Sanofi Tops Q2 Earnings, Revenues Grow Y/Y, Maintains View - Analyst Blog
Jul 31 / Zacks.com
Forget Biogen, Buy These Promising Biotech Stocks Instead - Analyst Blog
Jul 27 / Zacks.com
The Zacks Analyst Blog Highlights: Biogen, AbbVie, Regeneron, Amgen and XOMA - Press ...
Jul 30 / Zacks.com
Stock Market News for July 27, 2015 - Market News
Jul 27 / Zacks.com
Sanofi & Regeneron Enter Immuno-Oncology Collaboration - Analyst Blog
Jul 29 / Zacks.com
The Zacks Analyst Blog Highlights: Amgen, Exelixis, Regeneron, Five Prime Therapeutic...
Jul 23 / Zacks.com
Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA...
Jul 29 / Zacks.com
Amgen's Repatha Gains EU Nod; First PCSK9 Drug Approved - Analyst Blog
Jul 22 / Zacks.com
Struggling Sanofi Sends Cancer SOS to Regeneron and Another Vanity Biotech IPO Launch...
Jul 28 / TheStreet.com
Alzheimer's treatment reflects growing hopes for drugmakers
Jul 22 / FT.com
The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Rege...
Jul 28 / Zacks.com
Biotech Stock Roundup: Amgen PCSK9 Inhibitor First to Gain Approval, Exelixis Up on P...
Jul 22 / Zacks.com
Today's Momo Momentum Stock Is Regeneron Pharmaceuticals (REGN)
Jul 28 / TheStreet.com
Amgen and Sanofi to battle for cholesterol-busting crown
Jul 22 / FT.com
Is The Biotech Bull Market Still Intact?
Jul 27 / Investing Channel
Netflix stock just got 'cheaper.' Will you buy?
Jul 15 / CNNMoney.com
Regeneron Pharmaceuticals and Sanofi Grab a Blockbuster FDA Approval
Jul 27 / MotleyFool.com